Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
8 studies found for:    19188334 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed A Safety and Efficacy Study of Dexmedetomidine in ICU Patients Requiring Continuous Sedation
Condition: Mechanically Ventilated and Intubated Subjects
Interventions: Drug: Dexmedetomidine HCL Injection;   Drug: Midazolam Injection
2 Terminated Dexmedetomidine (Precedex®) for Severe Alcohol Withdrawal Syndrome (AWS) and Alcohol Withdrawal Delirium (AWD)
Conditions: Alcohol Withdrawal Delirium;   Alcohol Withdrawal Associated Autonomic Hyperactivity;   Alcohol Withdrawal Hallucinosis;   Alcohol Withdrawal-Induced Delirium Tremens
Interventions: Drug: Dexmedetomidine;   Drug: Placebo
3 Not yet recruiting Pain, Agitation and Delirium (PAD) Protocol in the Duke CICU
Conditions: Deep Sedation;   Ventilators, Mechanical;   Critical Illness
Interventions: Drug: Midazolam;   Drug: Propofol;   Drug: Dexmedetomidine
4 Completed Dexmedetomidine vs Midazolam for Intraoperative Sedation
Conditions: Failed Moderate Sedation During Procedure;   Minimally Conscious State
Interventions: Drug: Dexmedetomidine;   Drug: Midazolam
5 Completed
Has Results
Etomidate vs. Midazolam for Sedation During ERCP
Conditions: Choledocholithiasis;   Cholangiocarcinoma;   Pancreatitis;   Pancreatic Cancer
Interventions: Drug: Etomidate;   Drug: Midazolam;   Drug: Meperidine
6 Withdrawn Pilot Study Comparing Treatment With Dexmedetomidine to Midazolam for Symptom Control in Advanced Cancer Patients
Conditions: Pain Intractable;   Delirium;   Dyspnea;   Nausea
Interventions: Drug: Dexmedetomidine;   Drug: Midazolam
7 Unknown  Enteral Versus Intravenous Sedation in Critically Ill High-risk ICU Patients
Conditions: Critical Illness;   Mechanical Ventilation Complication
Interventions: Procedure: Enteral Sedation (EN);   Procedure: Control group: Intravenous Sedation (IV)
8 Completed Dynamic Light Application to Prevent ICU Acquired Delirium
Conditions: Delirium;   Confusion
Intervention: Other: Dynamic Light

Study has passed its completion date and status has not been verified in more than two years.